119 related articles for article (PubMed ID: 3712213)
1. Prediction of serum concentration time course of quinidine in human using a physiologically based pharmacokinetic model developed from the rat.
Harashima H; Sawada Y; Sugiyama Y; Iga T; Hanano M
J Pharmacobiodyn; 1986 Feb; 9(2):132-8. PubMed ID: 3712213
[TBL] [Abstract][Full Text] [Related]
2. Prediction of the disposition of nine weakly acidic and six weakly basic drugs in humans from pharmacokinetic parameters in rats.
Sawada Y; Hanano M; Sugiyama Y; Iga T
J Pharmacokinet Biopharm; 1985 Oct; 13(5):477-92. PubMed ID: 3938813
[TBL] [Abstract][Full Text] [Related]
3. Prediction of the plasma concentration time courses of various drugs in humans based on data from rats.
Sawada Y; Harashima H; Hanano M; Sugiyama Y; Iga T
J Pharmacobiodyn; 1985 Sep; 8(9):757-66. PubMed ID: 4087135
[TBL] [Abstract][Full Text] [Related]
4. Effect of amiodarone on the pharmacokinetics of phenytoin, quinidine, and lidocaine in the rat.
Fruncillo RJ; Kozin SH; DiGregorio GJ
Res Commun Chem Pathol Pharmacol; 1985 Dec; 50(3):451-4. PubMed ID: 4081327
[TBL] [Abstract][Full Text] [Related]
5. Disposition of antipyrine and phenytoin correlated with age and liver volume in man.
Bach B; Hansen JM; Kampmann JP; Rasmussen SN; Skovsted L
Clin Pharmacokinet; 1981; 6(5):389-96. PubMed ID: 7333060
[TBL] [Abstract][Full Text] [Related]
6. Influence of rifampicin on drug metabolism: differences between hexobarbital and antipyrine.
Breimer DD; Zilly W; Richter E
Clin Pharmacol Ther; 1977 Apr; 21(4):470-81. PubMed ID: 849678
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of drugs in rabbits with experimental acute renal failure.
Van Peer A; Belpaire F; Bogaert M
Pharmacology; 1978; 17(6):307-14. PubMed ID: 733890
[TBL] [Abstract][Full Text] [Related]
8. Analysis of nonlinear tissue distribution of quinidine in rats by physiologically based pharmacokinetics.
Harashima H; Sawada Y; Sugiyama Y; Iga T; Hanano M
J Pharmacokinet Biopharm; 1985 Aug; 13(4):425-40. PubMed ID: 4087170
[TBL] [Abstract][Full Text] [Related]
9. Correlation between the in vivo metabolism of hexobarbital and antipyrine in rats.
van der Graaff M; Vermeulen NP; Joeres RP; Vlietstra T; Breimer DD
J Pharmacol Exp Ther; 1983 Nov; 227(2):459-65. PubMed ID: 6631725
[TBL] [Abstract][Full Text] [Related]
10. Correlation between the in vivo metabolism of hexobarbital and antipyrine in rats with a portacaval shunt.
van der Graaff M; Vermeulen NP; Joeres RP; Breimer DD
Pharmacology; 1984; 29(2):99-109. PubMed ID: 6473507
[TBL] [Abstract][Full Text] [Related]
11. Effects of urea on hexobarbital and antipyrine disposition in rats.
Valentovic M; Bachmann K
Pharmacology; 1980; 21(3):167-74. PubMed ID: 7413718
[TBL] [Abstract][Full Text] [Related]
12. Comparative physiologically based pharmacokinetics of hexobarbital, phenobarbital and thiopental in the rat.
Igari Y; Sugiyama Y; Awazu S; Hanano M
J Pharmacokinet Biopharm; 1982 Feb; 10(1):53-75. PubMed ID: 7069578
[TBL] [Abstract][Full Text] [Related]
13. Prediction of hepatic extraction ratio from in vitro measurement of intrinsic clearance.
Rane A; Wilkinson GR; Shand DG
J Pharmacol Exp Ther; 1977 Feb; 200(2):420-4. PubMed ID: 839445
[TBL] [Abstract][Full Text] [Related]
14. Dose-dependent kinetics of quinidine in the perfused rat liver preparation. Kinetics of formation of active metabolites.
Yu VC; de Lamirande E; Horning MG; Pang KS
Drug Metab Dispos; 1982; 10(6):568-72. PubMed ID: 6130901
[TBL] [Abstract][Full Text] [Related]
15. Monthly variations in the clearance of antipyrine in the rat.
Bélanger PM; Doré F; Labrecque G
Res Commun Chem Pathol Pharmacol; 1984 Oct; 46(1):53-65. PubMed ID: 6505390
[TBL] [Abstract][Full Text] [Related]
16. Induction of hexobarbital and antipyrine metabolism by rifampicin treatment in the pig.
van den Broek JM; Teunissen MW; Breimer DD
Drug Metab Dispos; 1981; 9(6):541-4. PubMed ID: 6120813
[TBL] [Abstract][Full Text] [Related]
17. The effect of fenfluramine on disposition and rate of antipyrine elimination.
O'Malley K; Stevenson IH; West M
Pharmacology; 1975; 13(1):12-9. PubMed ID: 1153500
[TBL] [Abstract][Full Text] [Related]
18. [Influence of rifampicin on the metabolic clearance of galactose and antipyrine as compared with hexobarbital].
Zilly W; Wernze H; Buchenau D; Breimer DD; Richter E
Verh Dtsch Ges Inn Med; 1975; 81():1677-80. PubMed ID: 1227056
[No Abstract] [Full Text] [Related]
19. A physiologically based pharmacokinetic model to predict the pharmacokinetics of highly protein-bound drugs and the impact of errors in plasma protein binding.
Ye M; Nagar S; Korzekwa K
Biopharm Drug Dispos; 2016 Apr; 37(3):123-41. PubMed ID: 26531057
[TBL] [Abstract][Full Text] [Related]
20. Interspecies variation in liver weight, hepatic blood flow, and antipyrine intrinsic clearance: extrapolation of data to benzodiazepines and phenytoin.
Boxenbaum H
J Pharmacokinet Biopharm; 1980 Apr; 8(2):165-76. PubMed ID: 6107379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
